Finch throws in the towel on microbiome journey, lets go of 77 employees

Finch Therapeutics’ attempt to make crapsules that help prevent the recurrence of a bacterial infection is nearing the end of the road.

For the third time in nine months, the Boston-area biotech will lay off staffers, this time 95%, which equates to 77 employees.